Boltwood Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-2,975
| Closed | -$455K | – | 151 |
|
|
2021
Q1 | $455K | Sell |
2,975
-195
| -6% | -$29.8K | 0.2% | 108 |
|
|
2020
Q4 | $495K | Sell |
3,170
-160
| -5% | -$25K | 0.24% | 100 |
|
|
2020
Q3 | $381K | Buy |
3,330
+5
| +0.2% | +$572 | 0.21% | 106 |
|
|
2020
Q2 | $373K | Hold |
3,325
| – | – | 0.23% | 100 |
|
|
2020
Q1 | $299K | Buy |
3,325
+955
| +40% | +$85.9K | 0.21% | 111 |
|
|
2019
Q4 | $256K | Sell |
2,370
-4,900
| -67% | -$529K | 0.14% | 130 |
|
|
2019
Q3 | $712K | Buy |
7,270
+240
| +3% | +$23.5K | 0.45% | 77 |
|
|
2019
Q2 | $921K | Buy |
+7,030
| New | +$921K | 0.59% | 57 |
|